Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 1966 AL 1980

Symptomatic and Disease-Modifying Therapy Pipeline for Alzheimer's Disease: Towards a Personalized Polypharmacology Patient-Centered Approach

Morató X, Pytel V, Jofresa S, Ruiz A, Boada M.

Int J Mol Sci. 2022 Aug 18;23(16):9305. doi: 10.3390/ijms23169305.

Comparative Bioavailability Study of a Novel Multi-Day Patch Formulation of Rivastigmine (Twice Weekly) with Exelon® Transdermal Patch (Daily)- A Randomized Clinical Trial

Schurad B, Koch C, Schug B, Morte A, Vaqué A, De la Torre R, Iniesta M.

Curr Alzheimer Res. 2022;19(7):541-553. doi: 10.2174/1567205019666220823105059.

A systematic review on drugs for synaptic plasticity in the treatment of dementia

Piscopo P, Crestini A, Carbone E, Rivabene R, Ancidoni A, Lo Giudice M, Corbo M, Vanacore N, Lacorte E.

Ageing Res Rev. 2022 Nov;81:101726. doi: 10.1016/j.arr.2022.101726. Epub 2022 Aug 27.

TFEB in Alzheimer's disease: From molecular mechanisms to therapeutic implications

Gu Z, Cao H, Zuo C, Huang Y, Miao J, Song Y, Yang Y, Zhu L, Wang F.

Neurobiol Dis. 2022 Oct 15;173:105855. doi: 10.1016/j.nbd.2022.105855. Epub 2022 Aug 27.

γ-Secretase as a drug target for familial Alzheimer's disease: the road less traveled

Wolfe MS.

Future Med Chem. 2022 Oct;14(19):1341-1343. doi: 10.4155/fmc-2022-0178. Epub 2022 Aug 30.

Carthamus tinctorius L.: A natural neuroprotective source for anti-Alzheimer's disease drugs

Liang Y, Wang L.

J Ethnopharmacol. 2022 Nov 15;298:115656. doi: 10.1016/j.jep.2022.115656. Epub 2022 Aug 27.

Neuroinflammation and Oxidative Stress in Alzheimer's Disease; Can Nutraceuticals and Functional Foods Come to the Rescue?

Onaolapo OJ, Olofinnade AT, Ojo FO, Onaolapo AY.

Antiinflamm Antiallergy Agents Med Chem. 2022;21(2):75-89. doi: 10.2174/1871523021666220815151559.

Toll-Like Receptor 4: A Promising Therapeutic Target for Alzheimer's Disease

Wu L, Xian X, Xu G, Tan Z, Dong F, Zhang M, Zhang F.

Mediators Inflamm. 2022 Aug 21;2022:7924199. doi: 10.1155/2022/7924199. eCollection 2022.

Targeting Novel microRNAs in Developing Novel Alzheimer's Disease Treatments

Seyedaghamiri F, Rajabi M, Mohaddes G.

Neurochem Res. 2023 Jan;48(1):26-38. doi: 10.1007/s11064-022-03734-6. Epub 2022 Sep 1.

Ever-expanding landscape: Alzheimer's - new targets and new patents

Egunlusi AO, Joubert J.

Pharm Pat Anal. 2022 Sep;11(5):135-138. doi: 10.4155/ppa-2022-0031. Epub 2022 Sep 2.

Targeted Mitochondrial Epigenetics: A New Direction in Alzheimer's Disease Treatment

Song Y, Zhu XY, Zhang XM, Xiong H.

Int J Mol Sci. 2022 Aug 26;23(17):9703. doi: 10.3390/ijms23179703.

Combination Therapy for the Treatment of Alzheimer's Disease: Recent Progress and Future Prospects

Shirbhate E, Patel VK, Tiwari P, Kore R, Veerasamy R, Mishra A, Rajak H.

Curr Top Med Chem. 2022;22(22):1849-1867. doi: 10.2174/1568026622666220907114443.

Supplementation With Carotenoids, Omega-3 Fatty Acids, and Vitamin E Has a Positive Effect on the Symptoms and Progression of Alzheimer's Disease

Nolan JM, Power R, Howard AN, Bergin P, Roche W, Prado-Cabrero A, Pope G, Cooke J, Power T, Mulcahy R.

J Alzheimers Dis. 2022;90(1):233-249. doi: 10.3233/JAD-220556.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias